In last trading session, Corcept Therapeutics Inc (NASDAQ:CORT) saw 1.15 million shares changing hands with its beta currently measuring 0.15. Company’s recent per share price level of $73.36 trading at $2.52 or 3.56% at ring of the bell on the day assigns it a market valuation of $7.78B. That closing price of CORT’s stock is at a discount of -59.94% from its 52-week high price of $117.33 and is indicating a premium of 62.79% from its 52-week low price of $27.30.
For Corcept Therapeutics Inc (CORT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.19 in the current quarter.
Corcept Therapeutics Inc (NASDAQ:CORT) trade information
Upright in the green during last session for gaining 3.56%, in the last five days CORT remained trading in the green while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $73.36 price level, adding 0.29% to its value on the day. Corcept Therapeutics Inc’s shares saw a change of 45.58% in year-to-date performance and have moved 2.77% in past 5-day. Corcept Therapeutics Inc (NASDAQ:CORT) showed a performance of 5.42% in past 30-days.
Wall Street analysts have assigned a consensus price target of 140 to the stock, which implies a rise of 47.6% to its current value. Analysts have been projecting 135 as a low price target for the stock while placing it at a high target of 145. It follows that stock’s current price would drop -84.02% in reaching the projected high whereas dropping to the targeted low would mean a loss of -84.02% for stock’s current value.
Corcept Therapeutics Inc (CORT) estimates and forecasts
This year revenue growth is estimated to rise 33.18% from the last financial year’s standing.
4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 199.39M for the same. And 4 analysts are in estimates of company making revenue of 247.54M in the next quarter. Company posted 163.8M and 182.55M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.89% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.05% while estimates for its earnings growth in next 5 years are of 69.46%.
Corcept Therapeutics Inc (NASDAQ:CORT)’s Major holders
BLACKROCK INC. is the top institutional holder at CORT for having 16.54 million shares of worth $537.36 million. And as of 2024-06-30, it was holding 16.0391 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 9.55 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2648 of outstanding shares, having a total worth of $310.4 million.
On the other hand, iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 5.77 shares of worth $423.02 million or 5.44% of the total outstanding shares. The later fund manager was in possession of 2.8 shares on Dec 31, 2024, making its stake of worth around $205.74 million in the company or a holder of 2.64% of company’s stock.
